Adding high-sensitivity cardiac troponin assays on top of conventional risk-prediction methods can potentially improve primary prevention efforts, according to a new meta-analysis. While best known ...

Use of sex-specific thresholds for high-sensitivity cardiac troponin I (hs-cTnI) in patients with suspected acute coronary syndrome identified five times more additional women than men with myocardial ...

The cardiac troponin test detects damage to the heart muscle. Troponin is a protein that appears in the blood only when the heart muscle is damaged, as in a heart attack. There are other causes of ...

When used to evaluate suspected NSTEMI among patients who present to the emergency department (ED), high-sensitivity cardiac troponin T (hs-cTnT) and troponin I (hs-cTnI) diverge for both diagnosis ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A single high-sensitivity troponin I test below 2 ng/L ...

In a recent study published in the journal BMJ, a team of researchers from the United Kingdom evaluated the use of a high-sensitivity assay to measure cardiac troponin I and its impact on myocardial ...

Switching from a conventional to a high-sensitivity cardiac troponin I assay in emergency departments is associated with a reduction in both mortality at 1 year and new admissions for myocardial ...

To the Editor: Devereaux et al. (March 3 issue) 1 have made an important contribution to the characterization of appropriate thresholds for defining myocardial damage with the use of high-sensitivity ...

(RTTNews) - QuidelOrtho (QDEL) announced the FDA has granted 510(k) clearance for the VITROS hs Troponin I Reagent Pack. The assay is intended for the quantitative measurement of cardiac troponin I in ...

SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted QuidelOrtho Corporation (QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, 510(k) ...